Listing with Walgreens in the USA

TyraTech, Inc.

("TyraTech" or the "Company")

Vamousse® head lice treatment now distributed by Walgreens in the USA

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is pleased to announce that it has secured a listing for its Vamousse Treatment product with Walgreens in the USA.

Walgreens

Through the merger of Walgreens and Alliance Boots completed in December 2014, Walgreens Boots Alliance is now the first global pharmacy-led, health and wellbeing enterprise in the world. In the USA, Walgreens is the largest pharmacy chain with more than 8,000 stores. The Walgreens listing, which follows the recent announcement of the Vamousse listing with CVS as well as with the top three pharmaceutical distributors in the USA, represents an additional key milestone for the roll-out of TyraTech's Vamousse products in the USA. It is expected that the Vamousse Treatment product will be available in the majority of Walgreens stores nationwide in the USA from May 2015.

Bruno Jactel, Chief Executive Officer, said: "The Walgreens listing, following the recent CVS listing and the listing with Walmart last year will put our Vamousse head lice treatment in three of the top four pharmacy retailers in the USA. This is a significant step in the implementation of our strategy of making our products widely available to customers and building a national brand in the US. The TyraTech team is committed, more than ever, to building a brand, expanding distribution for our Vamousse products and creating value for our shareholders.

Further information on Vamousse® is available on the Company's website at http://www.vamousselice.com/